Jepsen J V, Bruskewitz R C
Department of Surgery, University of Wisconsin Hospital and Clinics, Madison, USA.
Urol Clin North Am. 1998 Nov;25(4):545-54, vii. doi: 10.1016/s0094-0143(05)70046-x.
In the past decade, the symptom score has been considered the essential part of the evaluation of patients with lower urinary tract symptoms (LUTS). At the University of Wisconsin, the author's have stopped routine use of symptom scores because of their limited utility in dealing with the patient's concerns. Except from men electing invasive treatment, the authors do not serve the patients better with urodynamic testing either. Bothersomeness, not symptom score or objective measures is what drives the decision making process in benign prostatic hyperplasia (BPH) management. Generally, the authors now select patients for treatment according to the degree to which they are bothered by their LUTS.
在过去十年中，症状评分一直被视为下尿路症状（LUTS）患者评估的重要组成部分。在威斯康星大学，作者们已停止常规使用症状评分，因为其在处理患者担忧方面效用有限。除了选择侵入性治疗的男性患者外，作者们进行尿动力学检查也未更好地服务于患者。在良性前列腺增生（BPH）管理中，促使决策过程的是困扰程度，而非症状评分或客观指标。一般来说，作者们现在根据患者受LUTS困扰的程度来选择治疗对象。
